Publications
- Ocrelizumab in the treatment of multiple sclerosis - view of a neurologist and immunologist2018 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Pediatric multiple sclerosis : up-to date summary and case-report2014 | First Faculty of Medicine
- Interferon beta in the current treatment of multiple sclerosis2013 | First Faculty of Medicine
- Treatment intramuscular interferon beta-1a2013 | First Faculty of Medicine
- Interferon beta and the state of the art in treatment of relapsing-remitting multiple sclerosis +12007 | First Faculty of Medicine
- Interferon beta and the state of the art in treatment of relapsing-remitting multiple sclerosis2007 | Publication without faculty affiliation
- Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis2023 | First Faculty of Medicine, Third Faculty of Medicine
- To be or not to be vaccinated: The risk of MS or NMOSD relapse after COVID-19 vaccination and infection2022 | First Faculty of Medicine
- Neurology2021 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen, Second Faculty of Medicine, Central Library of Charles University
- Neuropsychiatry: a clinical guide for outpatient and clinical practice2020 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen, Second Faculty of Medicine
Loading network view...